Skip to content

Comparison of visual outcomes of different design aspheric intraocular lens implatation

Comparison of visual outcomes of different design aspheric intraocular lens implatation

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015638
Enrollment
Unknown
Registered
2018-04-12
Start date
2018-04-15
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

observation group 1:ABC design IOL implantation (iSert 251, HOYA)
observation group 2:ABC design IOL implantation (Vivinex, HOYA)
Control group 1:aspheric IOL implatation (SN60WF)
Control group 2:aspheric IOL implatation (ZCB00)

Sponsors

Department of Ophthalmology, the Fourth Affiliated Hospital of China Medical University, Eye Hospital of China Medical University, The Key Lenticular Laboratory of Liaoning Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients more than 40 years old needing cataract phacoemulsification and intraocular lens implantation and understanding the purpose of the study and be voluntary to sign the informed consent.

Exclusion criteria

Exclusion criteria: Patients with other serious coexisting ocular disease, and a history of trauma, zonular weakness, abnormal pupil, previous corneal refractive surgery and other researchers judged excluded patients

Design outcomes

Primary

MeasureTime frame
visual acuity;wavefront abberation;IOL decentration and tilt degree;

Secondary

MeasureTime frame
Objective visual quality;Contrast sensitivity;MTF;

Countries

China

Contacts

Public ContactJinsong Zhang

Department of Ophthalmology, the Fourth Affiliated Hospital of China Medical University, Eye Hospital of China Medical University, The Key Lenticular Laboratory of Liaoning Province

cmu4h-zjs@126.com+86 18900916888

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026